JCO Precision Oncology

Published by: American Society of Clinical Oncology  

People

  1. Ladanyi
    Ladanyi
  2. Riely
    Riely
  3. Arcila
    Arcila
  4. Berger
    Berger
  5. Shukla
    Shukla
  6. Drilon
    Drilon
  7. Rudin
    Rudin
  8. Offin
    Offin
  9. Chakravarty
    Chakravarty
  10. Kris
    Kris

Groups

  1. Department of Pathology and Laboratory Medicine (24)
  2. GSK Faculty (24)
  3. Human Oncology and Pathogenesis Program (24)
  4. Tow Center for Developmental Oncology (TCDO) (24)
  5. Department of Medicine (18)
  6. Solid Tumor Oncology Division (18)
  7. Sloan Kettering Institute Postdocs (14)
  8. Weinberg Fellows (14)
  9. Center for Molecular Imaging and Biotechnology (CMIB) (13)
  10. Epidemiology and Biostatistics (12)
Search Within
  1. "Marc Ladanyi"
Formats
  1. Journal Article (23)
  2. Review (1)
Groups
  1. Department of Pathology and Laboratory Medicine (24)
  2. GSK Faculty (24)
  3. Human Oncology and Pathogenesis Program (24)
  4. Tow Center for Developmental Oncology (TCDO) (24)
  5. Department of Medicine (18)
  6. Solid Tumor Oncology Division (18)

More Groups

People
  1. Marc Ladanyi (24)
  2. Ahmet Zehir (11)
  3. Gregory Riely (9)
  4. Maria Arcila (7)
  5. Michael Berger (7)
  6. Neerav Shukla (7)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (3)
  5. 2020 (3)
  6. 2019 (6)

More Years

Publishers
  1. American Society of Clinical Oncology (24)

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical activity of mitogen-activated protein kinase inhibitors in patients with MAP2K1 (MEK1)-mutated metastatic cancers
    Review

    Dankner, M.; Rousselle, E.; Petrecca, S.; Fabi, F.; Nowakowski, A.; Lazaratos, A. M.; Vincent Rajadurai, C.; Stein, A. J. B.; Bian, D.; Tai, P.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Response to crizotinib after entrectinib resistance in ROS1-rearranged, MET-amplified lung adenocarcinoma
    Journal Article

    Vaz, V. R.; Gandhi, M. M.; Ricciuti, B.; Alessi, J. V.; Elkrief, A.; Ladanyi, M.; Vanderbilt, C.; Pecci, F.; Aldea, M.; Barrichello, A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Combination of MDM2 and targeted kinase inhibitors results in prolonged tumor control in lung adenocarcinomas with oncogenic tyrosine kinase drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Smith, R. S.; Vojnic, M.; Hayashi, T.; Khodos, I.; Markov, V.; Liu, Z.; Lui, A. J. W.; Bloom, J. L.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Clinical and genomic features of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer
    Journal Article

    Thummalapalli, R.; Bernstein, E.; Herzberg, B.; Li, B. T.; Iqbal, A.; Preeshagul, I.; Santini, F. C.; Eng, J.; Ladanyi, M.; Yang, S. R.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Clinical targeted next-generation panel sequencing reveals MYC amplification is a poor prognostic factor in osteosarcoma
    Journal Article

    Marinoff, A. E.; Spurr, L. F.; Fong, C.; Li, Y. Y.; Forrest, S. J.; Ward, A.; Doan, D.; Corson, L.; Mauguen, A.; Pinto, N.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Prospective clinical genomic profiling of Ewing sarcoma: ERF and FGFR1 mutations as recurrent secondary alterations of potential biologic and therapeutic relevance
    Journal Article

    Ogura, K.; Elkrief, A.; Bowman, A. S.; Koche, R. P.; de Stanchina, E.; Benayed, R.; Mauguen, A.; Mattar, M. S.; Khodos, I.; Meyers, P. A.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • SRC family kinase inhibition targets YES1 and YAP1 as primary drivers of lung cancer and as mediators of acquired resistance to ALK and epidermal growth factor receptor inhibitors
    Journal Article

    Sato, H.; Kubota, D.; Qiao, H.; Jungbluth, A.; Rekhtman, N.; Schoenfeld, A. J.; Yu, H. A.; Riely, G. J.; Toyooka, S.; Lovly, C. M.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Matched molecular profiling of cell-free DNA and tumor tissue in patients with advanced clear cell renal cell carcinoma
    Journal Article

    Kotecha, R. R.; Gedvilaite, E.; Ptashkin, R.; Knezevic, A.; Murray, S.; Johnson, I.; Shapnik, N.; Feldman, D. R.; Carlo, M. I.; Shah, N. J.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Clinical outcome of leiomyosarcomas with somatic alteration in homologous recombination pathway genes
    Journal Article

    Rosenbaum, E.; Jonsson, P.; Seier, K.; Qin, L. X.; Chi, P.; Dickson, M.; Gounder, M.; Kelly, C.; Keohan, M. L.; Nacev, B.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Aggressive hematopoietic malignancy characterized by biallelic loss of SMARCB1
    Journal Article

    Kinnaman, M. D.; Hamill, D.; Yabe, M.; Powell, J.; Benhamida, J.; Hasselblatt, M.; Neumann, M.; Vokuhl, C.; Koelsche, C.; von Deimling, A.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save

    • JCO Precision Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 Unknown
    Jco Precision Oncology Lippincott Williams & Wilkins
    Jco Precision Oncology American Society of Clinical Oncology
    Jco Precision Oncology American Society of Clinical Oncology
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    Unknown (24734284) 24734284 American Society of Clinical Oncology